---
title: "Insights into AtriCure's Upcoming Earnings"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/276075851.md"
description: "AtriCure (NASDAQ:ATRC) will report its quarterly earnings on February 17, 2026, with analysts estimating an EPS of $-0.04. Investors are keenly awaiting the announcement for potential positive guidance. Last quarter, AtriCure beat EPS estimates by $0.10, but shares fell 3.81% afterward. Currently, shares are priced at $31.8, down 14.57% over the past year. Analyst ratings and market sentiments are crucial for investors as they prepare for the earnings release."
datetime: "2026-02-16T20:01:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276075851.md)
  - [en](https://longbridge.com/en/news/276075851.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276075851.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/276075851.md) | [繁體中文](https://longbridge.com/zh-HK/news/276075851.md)


# Insights into AtriCure's Upcoming Earnings

**AtriCure** (NASDAQ:ATRC) is set to give its latest quarterly earnings report on Tuesday, 2026-02-17. Here's what investors need to know before the announcement.

Analysts estimate that AtriCure will report an **earnings per share** (EPS) of $-0.04.

The announcement from AtriCure is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

### Historical Earnings Performance

During the last quarter, the company reported an EPS beat by $0.10, leading to a 3.81% drop in the share price on the subsequent day.

Here's a look at AtriCure's past performance and the resulting price change:

**Quarter**

**Q3 2025**

**Q2 2025**

**Q1 2025**

**Q4 2024**

**EPS Estimate**

\-0.11

\-0.16

\-0.22

\-0.15

**EPS Actual**

\-0.01

\-0.02

\-0.14

\-0.08

**Price Change %**

\-4.00

11.00

\-14.00

\-7.00

![eps graph](https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771272088_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

### AtriCure Share Price Analysis

Shares of AtriCure were trading at $31.8 as of February 12. Over the last 52-week period, shares are down 14.57%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

### Analyst Opinions on AtriCure

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on AtriCure.

With analyst ratings, AtriCure has a consensus rating of . The average one-year price target is $, indicating a potential .

To track all earnings releases for AtriCure visit their earnings calendar on our site.

_This article was generated by Benzinga's automated content engine and reviewed by an editor._

### 相关股票

- [Atricure (ATRC.US)](https://longbridge.com/zh-CN/quote/ATRC.US.md)

## 相关资讯与研究

- [A Look At AtriCure (ATRC) Valuation After Strong 2025 Earnings And Upbeat 2026 Outlook](https://longbridge.com/zh-CN/news/277642139.md)
- [AtriCure (ATRC) Projected to Post Earnings on Tuesday](https://longbridge.com/zh-CN/news/275412692.md)
- [AtriCure beats Q4 profit estimates](https://longbridge.com/zh-CN/news/276168068.md)
- [AtriCure (NASDAQ:ATRC)  Shares Down 4.7%  on Insider Selling](https://longbridge.com/zh-CN/news/267724820.md)
- [AtriCure (NASDAQ:ATRC) Updates FY 2025 Earnings Guidance](https://longbridge.com/zh-CN/news/263628182.md)